A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone

PHASE3CompletedINTERVENTIONAL
Enrollment

507

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

January 31, 2013

Conditions
Essential Hypertension
Interventions
DRUG

Azilsartan medoxomil/placebo

Azilsartan medoxomil and placebo to chlorthalidone combination tablets

DRUG

Azilsartan medoxomil - chlorthalidone

Azilsartan medoxomil and chlorthalidone fixed dose combination tablets

Trial Locations (108)

Unknown

Haskovo

Pazardzhik

Pleven

Plovdiv

Sofia

Varna

Veliko Tarnovo

Paide

Saku

Tallinn

Tartu

Võru

Labarthe-sur-Lèze

Bourg-des-Comptes

Tours

Vourey

Saint-Étienne-de-Montluc

Orthez

Karlsruhe

Bad Wörishofen

Nuremberg

Hamburg

Frankfurt am Main

Stuhr

Essen

Kamp-Lintfort

Mainz

Dresden

Budapest

Debrecen

Gyöngyös

Gyula

Mosonmagyaróvár

Nyíregyháza

Pécs

Szikszó

Torrette Di Ancona

Acquaviva delle Fonti

Brescia

Ferrara

L’Aquila

Milan

Palermo

Pavia

Pisa

Roma

Sassari

Legnago

Bologna

Alytus

Kaunas

Beek

Breda

Eindhoven

Groningen

Leiderdorp

Maastricht

Rotterdam

Velp

Zoetermeer

Zwijndrecht

Bydgoszcz

Gdansk

Gdynia

Krakow

Lodz

Lublin

Oświęcim

Parczew

Poznan

Pulway

Rzeszów

Sopot

Torun

Zgierz

Belgrade

Kamenitz

Kragujevac

Kruševac

Niš

Zemun

Bardejov

Bratislava

Galanta

Komárno

Košice

Lučenec

Martin

Nitra

Nové Zámky

Prešov

Svidník

Žilina

Barcelona

Centelles

Madrid

Málaga

Gothenburg

Lund

Malmo

Vällingby

London

Glasgow

Blackpool

Northwood

Bath

Royal Leamington Spa

Westbury

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY